SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Tralokinumab (Adtralza)

Author: Natalia Abesada



Answer:

Anti IL13, Ind: dermatite atopique EI: Infections de voies respiratoires, reaction au site d'injection, conjonctivites ou eosinophilies. PAS administrer de vaccins vivants.


0 / 5  (0 ratings)

1 answer(s) in total